PC6 injection enhanced the preventive effect against postoperative nausea of granisetron compared with intravenous injection in gynecological laparoscopic patients: a randomized controlled study
In brief
Acupuncture-point granisetron cut postoperative nausea from 33% to 15%
In a randomized trial of 244 women having gynecologic laparoscopic surgery, moderate-to-severe nausea within 24 hours affected 14.8% of those given granisetron at the PC6 acupuncture point, versus 32.8% with intravenous granisetron. All patients also received dexamethasone; whether this approach works in other surgical groups or reduces vomiting remains unclear.
- Journal
- Frontiers in pharmacology (Q1)
- Published
- 26 October 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Jianying Song, Jia Tang, Juan Gu, Wanli Tian, Jin Zhou
- PMID
- 43005137
- DOI
- 10.3389/fphar.2026.1840347
Why clinicians should know about it
- Picked for Anesthesiology and Pain Medicine (paper of the day, 13 November 2026): Randomized trial of postoperative nausea prevention under general anaesthesia
Abstract
BACKGROUND: Moderate to severe postoperative nausea and vomiting significantly impedes recovery and is inadequately managed by current pharmacotherapy. This study investigates whether granisetron injection at the PC6 acupoint enhances prevention of postoperative moderate to severe postoperative nausea and vomiting compared to intravenous injection. METHODS: 244 participants undergoing elective gynecologic endoscopic surgery under general anesthesia were randomly assigned to PC6 granisetron group, IV granisetron group, PC6 saline group and control group. All patients receive 5 mg dexamethasone during anesthesia induction. At the end of surgery, 2 mg granisetron was injected at the PC6 acupoint in PC6 granisetron group, 2 mg granisetron was injected intravenously in IV granisetron group, 2 ml saline was injected at the PC6 acupoint in PC6 saline group, no additional measures to prevent postoperative nausea and vomiting in control group. RESULTS: The incidence of moderate-to-severe postoperative nausea in PC6 granisetron group was significantly lower than that in IV granisetron group, PC6 saline group and control group within 24 h after surgery. (14.8% [9/61] vs. 32.8% [20/61]; RR = 0.45, [95% CI: 0.22, 0.91]; P = 0.02 (14.8% [9/61] vs. 29.5% [18/61]; RR = 0.50 [95% CI: 0.24, 1.02]; P = 0.058, (14.8% [9/61] vs. 43.9% [25/57]; RR = 0.34 [95% CI: 0.17, 0.66]; P < 0.01.) These differences started from 2 h after surgery. There was no adverse events about PC6 acupoint injection was found. CONCLUSION: Granisetron injection at the PC6 acupoint enhances prevention of moderate-to-severe postoperative nausea within 24 h after surgery in patients undergoing elective gynecologic laparoscopic surgery under general anesthesia. CLINICAL TRIAL REGISTRATION: This study was registered at http://www.chictr.org.cn (ChiCTR2400085300).
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.